| Trial ID: | L0292 |
| Source ID: | NCT04722653
|
| Associated Drug: |
NNC0194-0499
|
| Title: |
A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Steatohepatitis
|
| Interventions: |
Drug: NNC0194-0499|Drug: Placebo (NNC0194-0499 )
|
| Outcome Measures: |
Number of treatment emergent adverse events (TEAEs)|AUC0-???, SD: The area under the NNC0194-0499 serum concentration-time curve from time 0 to infinity after a single s.c.(subcutaneous) administration|AUC0-tz, SD: The area under the NNC0194-0499 serum concentration-time curve from time 0 to the time of the last quantifiable sample after a single s.c. administration|AUC0-168h, SD: The area under the NNC0194-0499 serum concentration-time curve from time 0 to 168 hours after a single s.c. administration|Cmax, SD: Maximum concentration of NNC0194-0499 in serum after a single s.c. administration|tmax, SD: Time from dose administration to maximum serum concentration of NNC0194-0499 after a single s.c. administration|t??, SD: Terminal half-life of NNC0194-0499|CL/FSD: Apparent total serum clearance of NNC0194-0499|Vz/FSD: Apparent volume of distribution of NNC0194-0499 in the terminal phase|MRTSD: The mean residence time of NNC0194-0499 after a single s.c. administration
|
| Sponsor/Collaborators: |
Novo Nordisk A/S
|
| Gender: |
Male
|
| Age: |
20 Years to 55 Years ?? (Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
42
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
February 2, 2021
|
| Completion Date: |
April 27, 2021
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 4, 2021
|
| Locations: |
Novo Nordisk Investigational Site, Tokyo, Japan
|
| URL: |
https://ClinicalTrials.gov/show/NCT04722653
|
